Opinion: It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough
30 November 2022
The new drug lecanemab shows promise to one day treat Alzheimer's disease, but there's still a long way to go before it can be an effective and easily available treatment, writes Professor Jonathan Schott (UCL Queen Square Institute of Neurology) in The Guardian.
![Professor Jonathan Schott](https://www.ucl.ac.uk/news/sites/news/files/styles/large_image/public/jonschott8x5_0.jpg?itok=Rd8AMEpI)
Links
- Article in The Guardian
- Professor Jonathan Schott’s academic profile
- UCL Dementia Research Centre
- UCL Queen Square Institute of Neurology